Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,878,312
  • Shares Outstanding, K 30,467
  • Annual Sales, $ 2,109 M
  • Annual Income, $ 404,390 K
  • EBIT $ 476 M
  • EBITDA $ 505 M
  • 60-Month Beta 1.47
  • Price/Sales 4.62
  • Price/Cash Flow 23.47
  • Price/Book 12.33

Options Overview Details

View History
  • Implied Volatility 36.43% ( -0.15%)
  • Historical Volatility 34.69%
  • IV Percentile 56%
  • IV Rank 25.26%
  • IV High 69.72% on 10/21/24
  • IV Low 25.18% on 08/23/24
  • Put/Call Vol Ratio 11.45
  • Today's Volume 274
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 2,579
  • Open Int (30-Day) 2,510

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.05
  • Number of Estimates 4
  • High Estimate 3.16
  • Low Estimate 2.80
  • Prior Year 3.20
  • Growth Rate Est. (year over year) -4.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
310.29 +4.49%
on 03/21/25
348.00 -6.83%
on 03/10/25
-15.99 (-4.70%)
since 02/21/25
3-Month
310.29 +4.49%
on 03/21/25
375.00 -13.54%
on 02/06/25
-13.05 (-3.87%)
since 12/20/24
52-Week
302.01 +7.36%
on 10/22/24
459.77 -29.48%
on 07/17/24
-89.08 (-21.55%)
since 03/21/24

Most Recent Stories

More News
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 324.23 (+1.44%)
FTRE : 8.77 (unch)
AZTA : 37.43 (-0.95%)
RGEN : 140.02 (+0.49%)
CRL : 167.28 (+1.17%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 8.77 (unch)
MEDP : 324.23 (+1.44%)
AZTA : 37.43 (-0.95%)
WST : 228.68 (+0.51%)
IQV : 185.89 (+0.88%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 8.77 (unch)
MEDP : 324.23 (+1.44%)
RGEN : 140.02 (+0.49%)
AZTA : 37.43 (-0.95%)
IQV : 185.89 (+0.88%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 8.77 (unch)
MEDP : 324.23 (+1.44%)
AZTA : 37.43 (-0.95%)
CRL : 167.28 (+1.17%)
IQV : 185.89 (+0.88%)
2 Reasons to Watch MEDP and 1 to Stay Cautious

2 Reasons to Watch MEDP and 1 to Stay Cautious

MEDP : 324.23 (+1.44%)
Why Medpace (MEDP) Shares Are Trading Lower Today

Why Medpace (MEDP) Shares Are Trading Lower Today

MEDP : 324.23 (+1.44%)
Medpace: Q4 Earnings Snapshot

Medpace: Q4 Earnings Snapshot

MEDP : 324.23 (+1.44%)
Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

MEDP : 324.23 (+1.44%)
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

MEDP : 324.23 (+1.44%)
AZTA : 37.43 (-0.95%)
IQV : 185.89 (+0.88%)
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

Charles River Laboratories has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

MEDP : 324.23 (+1.44%)
XLV : 146.60 (-0.28%)
CRL : 167.28 (+1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 343.03
2nd Resistance Point 333.70
1st Resistance Point 328.96
Last Price 324.23
1st Support Level 314.89
2nd Support Level 305.56
3rd Support Level 300.82

See More

52-Week High 459.77
Fibonacci 61.8% 399.51
Fibonacci 50% 380.89
Fibonacci 38.2% 362.27
Last Price 324.23
52-Week Low 302.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar